Cryptococcosis: Difference between revisions

No edit summary
(Text replacement - "==References== " to "==References== <references/> ")
 
(13 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Can produce focal cerebral lesions or diffuse meningoencephalitis
*Can produce focal cerebral lesions or diffuse [[meningoencephalitis]]


==Clinical Features==
==Clinical Features==
#Fever
*[[Fever]]
#Headache
*[[Headache]]
#Nausea
*[[Nausea]]
#AMS
*[[altered mental status]]
#Focal neurologic deficits
*[[Focal neurologic deficits]]
*Meningismus is uncommon


==Diagnosis==
==Differential Diagnosis==
{{Headache DDX}}
 
==Evaluation==
*Neuroimaging usually normal
*Neuroimaging usually normal
*CSF
*'''CSF Studies'''
**Studies
**Crypto antigen (100% Sn & Sp)
***Crypto antigen (100% Sn & Sp)
**Crypto culture (95%-100% Sn)
***Crypto culture (95%-100% Sn)
**India Ink (60-80% Sn)
***India Ink (60-80% Sn)
*Opening pressure
**Opening pressure
**Usually elevated; drain CSF until pressure is <20 or 50% of opening presure
***Usually elevated; drain CSF until pressure is <20 or 50% of opening presure
*'''Serum'''
*Serum
**Cryptococcal antigen testing (95% Sn)
**Cryptococcal antigen testing (95% Sn)


==Treatment==
==Management==
#Amphotericin B 0.7mg/kg IV QD x 2 weeks
{{Cryptococcus Pneumonia}}
#Flucytosine 25mg/kg IV QID x2wk
{{Cryptococcus Meningitis}}
#Fluconazol 200mg BID x 8 weeks to clear CSF


==Disposition==
==Disposition==
*Admit
*Admit to Medicine with ID consult
*Once the CD4 count > 200 and the patient is asymptomatic therapy x 6 months, therapy can be discontinued
*Some patients can require longer durations of therapy depending on symptom persistence
 
==See Also==
*[[Fungal infections]]


==Source==
==References==
*Tintinalli
<references/>


[[Category:ID]]
[[Category:ID]]

Latest revision as of 01:13, 24 July 2017

Background

Clinical Features

Differential Diagnosis

Headache

Common

Killers

Maimers

Others

Aseptic Meningitis

Evaluation

  • Neuroimaging usually normal
  • CSF Studies
    • Crypto antigen (100% Sn & Sp)
    • Crypto culture (95%-100% Sn)
    • India Ink (60-80% Sn)
  • Opening pressure
    • Usually elevated; drain CSF until pressure is <20 or 50% of opening presure
  • Serum
    • Cryptococcal antigen testing (95% Sn)

Management

Pulmonary (not AIDS associated)

  • Fluconazole 400mg PO IV q24hrs x 6-12 months OR
  • Itraconazole 200mg PO q12hrs daily x 6-12 months OR
  • Voriconazole 200mg PO q12hrs x 6-12 months

Pulmonary (with AIDS)

  • Fluconazole 400mg PO q24hrs x 6-12 months

Meningitis (not AIDs associated)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 4 weeks
    • Followed by Fluconazole 400mg PO q24hrs x 8 weeks

Meningitis (with AIDS)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 2 weeks
  • Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome

Disposition

  • Admit to Medicine with ID consult
  • Once the CD4 count > 200 and the patient is asymptomatic therapy x 6 months, therapy can be discontinued
  • Some patients can require longer durations of therapy depending on symptom persistence

See Also

References